Results 191 to 200 of about 2,648 (201)

Retrospective and Prospective Disease Progression and Quality of Life in XLH

Case Medical Research, 2019
openaire   +1 more source

Monoklonaler Antikörper eröffnet neue Therapiechancen bei XLH

Pädiatrie, 2018
openaire   +1 more source

Burosumab: Neue Horizonte in der Behandlung der X-chromosomalen hypophosphatämischen Rachitis (XLH)

Osteologie, 2019
Adalbert Raimann
exaly  

Advancing Patient Evidence in XLH (APEX): Baseline analysis of a global data unification program

Bone
Thomas O Carpenter
exaly  

Association between work productivity and characteristics of adults with X-linked hypophosphatemia: an analysis of the XLH disease monitoring program

JBMR Plus
Annabel Nixon, Aliya Khan, Ben Johnson
exaly  

Antibody against FGF23 of potential benefit to patients with XLH

IBMS BoneKEy, 2014
openaire   +1 more source

Study of the Anti-FGF23 Antibody, Burosumab, in Adults With XLH

Case Medical Research, 2019
openaire   +1 more source

Nephrocalcinosis in patients with X-linked hypophosphataemia (XLH) is treatment-related,

Reactions Weekly, 1995
openaire   +1 more source

Health-related quality of life in French pediatric patients with X-linked hypophosphatemia: real-world data from the International XLH Registry Open Access

JBMR Plus
Diana-Alexandra Ertl, Justine Bacchetta, Annabel Nixon   +2 more
exaly  

Transizione dalla pediatria all’endocrinologo dell’adulto nei pazienti XLH

L'Endocrinologo
Francesca Aiello, Anna Grandone
openaire   +1 more source